Sabrina Martucci Johnson - 18 Feb 2026 Form 4 Insider Report for Dare Bioscience, Inc. (DARE)

Signature
/s/ Sabrina Martucci Johnson
Issuer symbol
DARE
Transactions as of
18 Feb 2026
Net transactions value
$0
Form type
4
Filing time
20 Feb 2026, 16:01:50 UTC
Previous filing
02 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
JOHNSON SABRINA MARTUCCI Chef Executive Officer, Director 3655 NOBEL DRIVE, SUITE 260, SAN DIEGO /s/ Sabrina Martucci Johnson 20 Feb 2026 0001199102

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DARE Series A Convertible Preferred Stock Award +10,800 10,800 18 Feb 2026 Common stock 21,600 $2.50 Direct F1, F2, F3, F4
transaction DARE Common Stock Warrant (right to buy) Award +21,600 21,600 18 Feb 2026 Common stock 21,600 $4.00 Direct F1, F2, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This date is the date on which the reporting person subscribed to purchase the securities. The securities will be issued at a future date when the Issuer accepts the reporting person's subscription.
F2 This security is convertible or exercisable, as applicable, at any time after issuance.
F3 The Series A Convertible Preferred Stock (the Preferred Stock) is perpetual and has no expiration date. The Issuer has the option to redeem the Preferred Stock and the right to require the conversion of the Preferred Stock into shares of the common stock of the Issuer (the Common Stock), in each case, subject to specified conditions.
F4 The reported securities are included within 10,800 Investor Units (the Units) purchased by the reporting person in the Regulation A offering of the Issuer for $5 per Unit. Each Unit consists of one share of Preferred Stock, each of which is initially convertible into two shares of Common Stock, and two warrants, each to purchase one share of Common Stock.
F5 This security expires on the 36-month anniversary of the date of issuance.